A detailed history of Walleye Capital LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 185,795 shares of TERN stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,795
Holding current value
$1.09 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $1.21 Million - $2.01 Million
185,795 New
185,795 $1.55 Million
Q4 2023

Feb 14, 2024

SELL
$3.37 - $6.86 $353,213 - $719,003
-104,811 Reduced 80.56%
25,295 $164,000
Q3 2023

Nov 14, 2023

SELL
$4.7 - $8.55 $1.01 Million - $1.84 Million
-215,393 Reduced 62.34%
130,106 $654,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.29 $2.54 Million - $4.59 Million
345,499 New
345,499 $3.02 Million
Q4 2022

Feb 14, 2023

BUY
$4.62 - $10.18 $284,069 - $625,937
61,487 Added 507.15%
73,611 $749,000
Q3 2022

Nov 14, 2022

BUY
$1.87 - $6.42 $22,671 - $77,836
12,124 New
12,124 $71,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.